Norepinephrine and Edoxaban Interaction
Drug interaction information between Norepinephrine and Edoxaban.
Norepinephrine and Edoxaban have a documented moderate interaction in FDA labeling.
FDA drug labeling documents a moderate-severity interaction between Norepinephrine and Edoxaban. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
Taking these medicines together can increase your risk of serious bleeding.
What To Do
Avoid using these drugs at the same time to prevent dangerous bleeding.
FDA Label Information
7 DRUG INTERACTIONS Anticoagulants, Antiplatelets, Thrombolytics, and Selective Serotonin Reuptake Inhibitors (SSRIs)/Serotonin Norepinephrine Reuptake Inhibitors (SNRIs): Avoid concomitant use due to increased risk of bleeding.
Norepinephrine Also Interacts With
- Tranylcypromine major
- Carbidopa/Levodopa moderate
- Clopidogrel moderate
- Deutetrabenazine moderate
- Digoxin moderate
Edoxaban Also Interacts With
- Rifampin moderate
- Aspirin minor
- Carbamazepine minor
- Darunavir minor
Frequently Asked Questions
Can I take Norepinephrine and Edoxaban together?
This is a moderate interaction. Avoid using these drugs at the same time to prevent dangerous bleeding.
How serious is the interaction between Norepinephrine and Edoxaban?
This interaction is classified as "moderate" severity by the FDA. Moderate interactions may worsen your condition or change how your medications work.
Why do Norepinephrine and Edoxaban interact?
Taking these medicines together can increase your risk of serious bleeding.
Understanding the Norepinephrine and Edoxaban Interaction
FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Norepinephrine belongs to the Vasopressor (Alpha-1 Agonist) class and Edoxaban belongs to the Direct Oral Anticoagulant (Factor Xa Inhibitor) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Taking these medicines together can increase your risk of serious bleeding. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Norepinephrine has 50 total documented interactions on file in this dataset, and Edoxaban has 5. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Avoid using these drugs at the same time to prevent dangerous bleeding. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Norepinephrine or Edoxaban based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.